Topical skin formulations
A method of treating dry skin or moisturizing skin is disclosed. The method can include topically applying to the skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei , and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus , wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.
1. A method of treating dry skin or skin in need of mosturization in a human in need thereof, the method comprising topically applying to the skin a composition comprising:
0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei ; and
0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus;
wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.
2. The method of claim 1 , wherein the skin permeability is decreased in the skin and wherein at least one of filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.
3. The method of claim 1 , wherein the hydrolyzed algae extract increases production of filaggrin, increases skin moisture, increases production of occludin, and/or decreases skin permeability in the skin.
4. The method of claim 1 , wherein the composition is formulated as at least one of a moisturizer, a mask, a foundation, a freshener, or a cleanser.
5. The method of claim 1 , wherein the composition further comprises 35% to 98% w/w of water.
6. The method of claim 1 , wherein the composition further comprises glycerin and phenoxyethanol.
7. The method of claim 6 , wherein the composition comprises 1% to 15% w/w of glycerin and 0.1% to 1.5% w/w of phenoxyethanol.
8. The method of claim 1 , wherein the saccharide isomerate increases production of filaggrin, increases skin moisture, increases production of occludin, or inhibits TNFα production in the skin.
9. The method of claim 8 , wherein the saccharide isomerate increases skin moisture.
10. The method of claim 1 , wherein skin permeability is decreased in the skin.
11. The method of claim 1 , wherein filaggrin production is increased in the skin.
12. The method of claim 1 , wherein skin moisture is increased in the skin.
13. The method of claim 1 , wherein occludin production is increased in the skin.
14. The method of claim 1 , wherein TNFα production is inhibited in the skin.
15. The method of claim 1 , wherein at least two of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.
16. The method of claim 1 , wherein skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, and TNFα production is inhibited in the skin.